Skip to content
value.today

CuraSen Therapeutics, Inc.

🇺🇸 San Mateo, California, USABiotechnologyFounded 2016
Total raised
$69 M
4 rounds on record
Latest round
$6 M
Aug 2024
First round on record
Sep 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CuraSen Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2024$6 MNo. 4$2 to $10 million

CuraSen Therapeutics, Inc.: Raise no. 4, Aug 2024

Investors in this round

7 investors had bought by the notice of Sep 18, 2024: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $46 M offered; $40 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anthony P. Ford · Executive Officer, Director
  • Benjamin Sereda Potter · Executive Officer
  • Kathleen Sereda Glaub · Director
  • Loretta Sereda Tse, Ph.D. · Director
  • Patrick Sereda Enright · Director
  • Ron Sereda Hunt · Director
  • Simon Sereda Tate, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony P. Ford, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 18, 2024. Read the notice at the SEC.

equitySEC
Nov 2022$18 MNo. 3$10 to $50 million

CuraSen Therapeutics, Inc.: Raise no. 3, Nov 2022

Investors in this round

11 investors had bought by the notice of Oct 12, 2023: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $21 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anthony P. Ford · Director, Executive Officer
  • Benjamin Sereda Potter · Executive Officer
  • Kathleen Sereda Glaub · Director
  • Loretta Sereda Tse, Ph.D. · Director
  • Patrick Sereda Enright · Director
  • Ron Sereda Hunt · Director
  • Simon Sereda Tate · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony P. Ford, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 12, 2023. Read the notice at the SEC.

equitySEC
Oct 2021$18 MNo. 2$10 to $50 million

CuraSen Therapeutics, Inc.: Raise no. 2, Oct 2021

Investors in this round

10 investors had bought by the notice of Nov 5, 2021: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anthony P Ford · Director, Executive Officer
  • Benjamin Sereda Potter · Executive Officer
  • Kathleen Sereda Glaub · Director
  • Loretta Sereda Tse, Ph.D. · Director
  • Patrick Sereda Enright · Director
  • Ron Sereda Hunt · Director
  • Simon Sereda Tate · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony P. Ford, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 5, 2021. Read the notice at the SEC.

equitySEC
Sep 2018$27 MNo. 1$10 to $50 million

CuraSen Therapeutics, Inc.: Raise no. 1, Sep 2018

Investors in this round

10 investors had bought by the notice of Jan 25, 2019: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$27 M of $55 M offered; $27 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anthony P. Ford · Executive Officer, Director
  • Benjamin Sereda Potter · Executive Officer
  • Henry Sereda Skinner · Director
  • Kathleen Sereda Glaub · Director
  • Liam Sereda Ratcliffe · Director
  • Patrick Sereda Enright · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony P. Ford, President & CEO. Source: SEC Form D, newest notice filed Jan 25, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CuraSen Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2024).

    SEC Form D · Sep 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2024

That is all the official record says: CuraSen Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of CuraSen Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CuraSen Therapeutics, Inc.
NameRoleNamed in
Anthony P. FordExecutive officerSep 2024
Benjamin Sereda PotterExecutive officerSep 2024
Anthony P FordExecutive officerNov 2021
Anthony P. FordDirectorSep 2024
Kathleen Sereda GlaubDirectorSep 2024
Loretta Sereda Tse, Ph.D.DirectorSep 2024
Patrick Sereda EnrightDirectorSep 2024
Ron Sereda HuntDirectorSep 2024
Simon Sereda Tate, Ph.D.DirectorSep 2024
Simon Sereda TateDirectorOct 2023
Anthony P FordDirectorNov 2021
Henry Sereda SkinnerDirectorJan 2019
Liam Sereda RatcliffeDirectorJan 2019